Pfizer director granted 7,686 phantom stock units

Echevarria Joseph reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Echevarria Joseph reported acquisition or exercise transactions in this Form 4 filing.

Pfizer Inc. director Joseph Echevarria received a grant of 7,686.539 Phantom Stock Units tied to common stock. The units were awarded as director compensation under Pfizer’s Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors and bring his reported phantom unit balance to 161,084.684. Each unit represents one phantom share and will be settled in cash or common stock, at his election, after he retires from the board.

Insider Trade Summary

Grant/Award: 7,686.539 shares

Grant/Award 1 txn

Insider Echevarria Joseph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	7,686.539	$26.67	$205K

Holdings After Transaction: Phantom Stock Units — 161,084.684 contracts (Direct)

Footnotes (3)

1. F1. Each unit represents one phantom share of common stock.
2. F2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
3. F3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom units granted: 7,686.539 units Reference price per unit: $26.67 per unit Total phantom units after grant: 161,084.684 units +2 more

5 metrics

Phantom units granted 7,686.539 units Grant of Phantom Stock Units on April 23, 2026

Reference price per unit $26.67 per unit Value used for Phantom Stock Unit grant

Total phantom units after grant 161,084.684 units Director’s Phantom Stock Unit balance following transaction

Underlying common stock 7,686.539 shares Underlying Pfizer common stock equivalent for new units

Conversion price $0.00 Conversion or exercise price for Phantom Stock Units

Key Terms

Phantom Stock Units, Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors, deferred director's compensation

3 terms

Phantom Stock Units financial

"security_title: "Phantom Stock Units""

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors financial

"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."

deferred director's compensation financial

"These units represent deferred director's compensation that are settled in cash or common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pfizer (PFE) report for Joseph Echevarria?

Pfizer reported that director Joseph Echevarria received 7,686.539 Phantom Stock Units as a grant of deferred director compensation. These units track Pfizer common stock value and are part of a nonfunded plan for non-employee directors.

How many Pfizer Phantom Stock Units does Joseph Echevarria hold after this grant?

After the April 23, 2026 grant, Joseph Echevarria holds a total of 161,084.684 Phantom Stock Units. This figure reflects his accumulated deferred director compensation linked to Pfizer’s common stock value under the company’s non-employee director plan.

At what reference price were Pfizer’s Phantom Stock Units granted to Joseph Echevarria?

The 7,686.539 Phantom Stock Units were granted at a reference price of $26.67 per unit. This price reflects the value used for the compensation grant calculation rather than a cash purchase in the open market.

How will Joseph Echevarria’s Pfizer Phantom Stock Units be settled?

Echevarria’s Phantom Stock Units will be settled in either cash or Pfizer common stock, at his election, following his retirement from the Board of Directors. This structure allows his director compensation to track the company’s share performance over time.

What does each Pfizer Phantom Stock Unit granted to Joseph Echevarria represent?

Each Phantom Stock Unit represents one phantom share of Pfizer common stock. The units mirror the economic value of actual shares but are part of a deferred compensation arrangement, paid in cash or stock at a later date instead of being traditional share ownership now.

Under which Pfizer compensation plan were Joseph Echevarria’s Phantom Stock Units granted?

The Phantom Stock Units were granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. This plan provides equity-linked deferred compensation to outside directors instead of immediate cash or stock payments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 06:37 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Echevarria Joseph

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	(1)	04/23/2026		A		7,686.539(2)		(3)	(3)	Common Stock	7,686.539	$26.67	161,084.684	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for Joseph J. Echevarria	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)